Chiesi USA Inc  

(Public, NASDAQ:CRTX)   Watch this stock  
Find more results for CRTX
0.0000
- Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week     -
Open     -
Vol. 0.00
Mkt cap     -
P/E 0.00
Div/yield     -
EPS 0.33
Shares 26.90M
Beta     -
Inst. own 16%

Key stats and ratios

Q3 (Sep '13) 2012
Net profit margin 17.84% -10.24%
Operating margin 29.87% -23.55%
EBITD margin - 20.30%
Return on average assets 10.05% -3.95%
Return on average equity 21.16% -6.97%
Employees 105 -
CDP Score - -

Address

1255 Crescent Grn Ste 250
CARY, NC 27518-8128
United States - Map
+1-919-6786611 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Chiesi USA, Inc. is a specialty pharmaceutical company. The Company is focused on commercializing products for the hospital and adjacent specialty markets. Its portfolio of products includes products for the hospital and adjacent specialties, as well as for treating rare diseases. Its product portfolio consists of CARDENE IV (nicardipine hydrochloride) Premixed Injection, BETHKIS (Tobramycin Inhalation Solution), CUROSURF (poractant alfa) Intratracheal Suspension, PERTZYE (pancrelipase) Delayed-Release Capsules, RETAVASE (reteplase, recombinant), ZYFLO (zileuton) Tablets and ZYFLO CR (zileuton) Extended-Release Tablets. The Company is focused on its commercial and development efforts in the hospital and adjacent specialty product sector within the United States pharmaceutical marketplace and generates revenues by marketing approved generic products through its subsidiary, Aristos Pharmaceuticals, Inc.

Officers and directors

Kenneth R. McBean President
Age: 48
Craig A. Collard Chief Executive Officer
Age: 48
Alastair S. McEwan Chief Financial Officer, Treasurer, Secretary
Age: 61
Andreas Maetzel Vice President - Clinical and Regulatory
Age: 50
Alan T. Roberts Vice President - Scientific Affairs
Age: 47
Joshua B. Franklin Vice President - Strategy and Business Development
Age: 44
Ugo Di Francesco Director